ELEDON PHARMACEUTICALS INC (ELDN) Stock News

USA - NASDAQ:ELDN - US28617K1016 - Common Stock

1.825 USD

-0.3 (-14.32%)

Last: 11/12/2025, 10:33:10 AM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ELDN Latest News, Press Relases and Analysis

All

Press Releases

2 hours ago - By: Chartmill - Mentions: FMFC GTI IHS CTW ...

News Image

Top movers in Wednesday's pre-market session

5 days ago - By: Chartmill - Mentions: RUBI STKS IFRX YGMZ ...

News Image

What's going on in today's after hours session

3 hours ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

3 hours ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

4 hours ago - By: Benzinga - Mentions: IRIX STXS SI LUCY ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

17 hours ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

17 hours ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

5 days ago - By: Chartmill - Mentions: FMFC GMED KODK RUBI ...

News Image

What's going on in today's session

5 days ago - By: Benzinga

Eledon Pharmaceuticals' Lead Asset Fails In Mid-Stage Study, But Pushes Forward With Pivotal Study

5 days ago - By: Chartmill - Mentions: GMED KODK RUBI BKYI ...

News Image

Keep an eye on the top gainers and losers in Friday's session.

5 days ago - By: Chartmill - Mentions: GMED PSIX KODK TNDM ...

News Image

These stocks are gapping in today's session

5 days ago - By: Chartmill - Mentions: OPEN GMED FOXF RUBI ...

News Image

Discover the top movers in Friday's pre-market session.

6 days ago - By: Eledon Pharmaceuticals, Inc.

Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology’s Kidney Week 2025 Annual Meeting

6 days ago - By: Eledon Pharmaceuticals, Inc.

Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology’s Kidney Week 2025 Annual Meeting

7 days ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Present at Guggenheim Second Annual Healthcare Innovation Conference

a month ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting

a month ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting

2 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association

2 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association

3 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Participate in Cantor Global Healthcare Conference 2025

3 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Participate in Cantor Global Healthcare Conference 2025

3 months ago - By: The Motley Fool

Eledon Posts Narrower Loss in Q2

3 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results

3 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results

3 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

3 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

3 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at the World Transplant Congress 2025

4 months ago - By: Eledon Pharmaceuticals, Inc.

Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025

4 months ago - By: Eledon Pharmaceuticals, Inc.

Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025

5 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City

5 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City